Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder (RESPOND)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04948151 |
Recruitment Status : Unknown
Verified June 2021 by Strategic Science & Technologies, LLC.
Recruitment status was: Recruiting
First Posted : July 1, 2021
Last Update Posted : July 1, 2021
|
Sponsor:
Strategic Science & Technologies, LLC
Collaborator:
Daré Bioscience, Inc.
Information provided by (Responsible Party):
Strategic Science & Technologies, LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | December 15, 2021 |
Estimated Study Completion Date : | December 15, 2021 |